Indefinite Delivery Contract 75N95021D00014
Award Date
5/1/21
Last Date to Order
4/30/26
Federal Agency
National Institute on Drug Abuse
Awardee
The Bizzell Group LLC
Ultimate Awardee
Not listed
PSC Category
R708 - Support- Management: Public Relations
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Bizzell Group LLC was awarded a single-award indefinite delivery contract by the National Institute on Drug Abuse within the Department of Health and Human Services. With a potential value of five hundred six thousand twenty-one dollars and four cents, this contract provides technical, logistical, and conference support for the Division of Therapeutics and Medical Consequences. No set-asides were applied to this award. The period of performance runs from the award date of September 27,...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a $49,500,000 ceiling value to The Emmes Company LLC, a for-profit limited liability company, to serve as the Clinical Coordinating Center for NIDA's Clinical Trials Network (CTN). The contract has a period of performance from August 15, 2024 to August 14, 2029. Under this IDC, NIDA has issued three task orders to date,...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
The National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award indefinite delivery contract to The Emmes Company LLC, a global clinical research organization, to provide a range of data, statistics, and clinical trial support services in support of NIDA's mission. The contract has a potential value of $33,253,342. Under this IDV, The Emmes Company LLC has been issued multiple task orders to provide specialized services such as data coordination, statistical...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $7 million indefinite delivery contract to Murty Pharmaceuticals, Inc., a small disadvantaged minority-owned business, for the development and manufacture of pharmaceutical products to support NIDA's substance abuse and addiction treatment research programs. Under this contract, Murty Pharmaceuticals performs a range of services including formulation development,...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, awarded an Indefinite Delivery Contract to Kelly Services, Inc. valued at up to $747,519,575. The contract provides for SCIENTIFIC, TECHNICAL, AND OTHER PROFESSIONAL SUPPORT SERVICES (STOPS) to support NIDA's biomedical research and public health initiatives. Kelly Services, a subsidiary of the woman-owned and Hispanic American-owned company...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...
The National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Toxicological Evaluations of Potential Medications" to Sri International, a non-profit research and development institute. The IDIQ has a ceiling value of $9,750,000 and a 5-year ordering period from September 12, 2023 through September 11, 2028. Under this IDIQ, Sri International will conduct...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15 million Indefinite Delivery Contract (IDC) to Rutgers, The State University to operate the NIDA Center for Genetic Studies. This single-award contract has a 5-year period of performance through March 2028. Under this IDC, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research...